This report provides a comprehensive analysis of the global gelatin haemostatic sponge market, projecting steady growth through 2032. It examines the industry landscape, including product types, forms, and applications across surgical departments such as neurosurgery, orthopedics, and dental care. Key market drivers include rising surgical volumes, the expansion of minimally invasive procedures, and an increasing focus on perioperative blood management. Additionally, the study evaluates competitive strategies, regional opportunities, and technological innovations shaping the future of surgical hemostasis.

Market Overview

The global Gelatin Haemostatic Sponge market is projected to grow from US$ 1125 million in 2025 to US$ 1482 million in 2032, representing a compound annual growth rate (CAGR) of 4.4% from 2026 to 2032.

Product Description

Gelatin Haemostatic Sponges are absorbable medical devices manufactured from purified gelatin. They are specifically designed to control bleeding by promoting clot formation when applied to surgical or traumatic wounds.

• Mechanism of Action: The porous sponge structure absorbs blood and concentrates platelets and clotting factors, creating a physical matrix that accelerates hemostasis.
• Versatility: These sponges can be cut to shape and may be used alone or combined with thrombin depending on the severity of the bleeding.
• Clinical Applications: They are widely utilized in general surgery, orthopedics, neurosurgery, ENT, and dental procedures.
• Key Performance Requirements:
• Rapid absorption
• Predictable biodegradation
• Biocompatibility
• Sterility assurance
• Consistent pore structure (to balance swelling and hemostatic efficacy)

Industrial Chain Analysis

Upstream Inputs

• Medical-grade gelatin raw material
• Purification reagents
• Water for injection
• Sterilization supplies
• Packaging films
• Labeling materials

Midstream Manufacturing

• Gelatin solution preparation
• Foaming or freeze-drying (to create porous structure)
• Molding and cutting
• Drying
• Sterilization (e.g., gamma or EO)
• Quality testing (for absorbency, endotoxin, bioburden, and mechanical integrity)

Downstream Users

• Hospitals
• Surgical centers
• Trauma care units
• Medical distributors

Services

• Clinical training
• Regulatory compliance support
• Post-market surveillance
• Supply chain assurance for sterile medical products

Market Economics

• Pricing Factors: Prices vary significantly based on brand tier, sponge format (e.g., sheets vs. dental cubes), sterility/pack configuration, and procurement channels (e.g., hospital contracts vs. retail).
• Profitability: The gross profit margin for major companies within the industry ranges between 10% and 30%.

Growth Drivers & Market Trends

• Key Drivers:
• Rising surgical volumes
• Expansion of minimally invasive procedures
• Increased focus on perioperative blood management
• Aging populations and a higher chronic disease burden
• Clinical Demand: Hospitals require fast, reliable local hemostasis to reduce operative time and transfusion risks, driving demand in general surgery, orthopedics, neurosurgery, and trauma care.
• Product Differentiation & Innovation:
• Competition is shifting from basic sponges toward combination hemostats and advanced bioresorbable matrices.
• Differentiation is driven by absorption speed, handling properties, swelling control, and compatibility with adjuncts like thrombin.
• Buyers prioritize sterility assurance, endotoxin control, and consistent batch performance under strict regulatory oversight.
• Market Influencers: Reimbursement policies, hospital procurement practices, and supply reliability for operating room continuity significantly influence product choice.

Market Segmentation

By Type

• Porcine Gelatin Sponge
• Cow Gelatin Sponge
• Others

By Product Form

• Sponge Sheets
• Sponge Particles
• Others

By Departments

• ENT and Dental Surgery
• Plastic Surgery
• Neuro surgery
• Others

By Application

• Hospital
• Clinic
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

• Pfizer
• Johnson & Johnson
• B. Braun
• Gelita Medical
• Cura Medical
• Aegis Lifesciences
• COLTENE
• Dispotech
• Ferrosan Medical Devices
• EUCARE Pharmaceuticals
• BOENMED
• Medelast
• JIAXING KENYUE
• Medzeel Lifescience
• Goodwill Lifesciences
• Equimedical
• Healthium Medtech
• Septodont
• Assut Europe
• Nanchang Hushida Medical Technology

About the Report

Produced by LP Information, Inc. (LPI), the “Gelatin Haemostatic Sponge Industry Forecast” provides a comprehensive analysis of the global landscape. The report reviews total world sales for 2025 and provides projected sales for 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

Key Analytical Focuses:

• Product segmentation, company formation, revenue, and market share.
• Latest developments and M&A activity.
• Leading company strategies (portfolios, capabilities, market entry, and geographic footprints).
• Market trends, drivers, and emerging pockets of opportunity using a transparent methodology based on hundreds of bottom-up qualitative and quantitative inputs.

Key Questions Addressed

• What is the 10-year outlook for the global Gelatin Haemostatic Sponge market?
• What factors are driving Gelatin Haemostatic Sponge market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Gelatin Haemostatic Sponge market opportunities vary by end market size?
• How does Gelatin Haemostatic Sponge break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Gelatin Haemostatic Sponge Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Gelatin Haemostatic Sponge by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Gelatin Haemostatic Sponge by Country/Region, 2021, 2025 & 2032

  • 2.2 Gelatin Haemostatic Sponge Segment by Type

    • 2.2.1 Porcine Gelatin Sponge

    • 2.2.2 Cow Gelatin Sponge

    • 2.2.3 Others

    • 2.2.4 Gelatin Haemostatic Sponge Sales by Type

      • 2.2.4.1 Global Gelatin Haemostatic Sponge Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Gelatin Haemostatic Sponge Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Gelatin Haemostatic Sponge Sale Price by Type (2021-2026)

  • 2.3 Gelatin Haemostatic Sponge Segment by Product Form

    • 2.3.1 Sponge Sheets

    • 2.3.2 Sponge Particles

    • 2.3.3 Others

    • 2.3.4 Gelatin Haemostatic Sponge Sales by Product Form

      • 2.3.4.1 Global Gelatin Haemostatic Sponge Sales Market Share by Product Form (2021-2026)
      • 2.3.4.2 Global Gelatin Haemostatic Sponge Revenue and Market Share by Product Form (2021-2026)
      • 2.3.4.3 Global Gelatin Haemostatic Sponge Sale Price by Product Form (2021-2026)

  • 2.4 Gelatin Haemostatic Sponge Segment by Departments

    • 2.4.1 ENT and Dental Surgery

    • 2.4.2 Plastic Surgery

    • 2.4.3 Neuro surgery

    • 2.4.4 Others

    • 2.4.5 Gelatin Haemostatic Sponge Sales by Departments

      • 2.4.5.1 Global Gelatin Haemostatic Sponge Sales Market Share by Departments (2021-2026)
      • 2.4.5.2 Global Gelatin Haemostatic Sponge Revenue and Market Share by Departments (2021-2026)
      • 2.4.5.3 Global Gelatin Haemostatic Sponge Sale Price by Departments (2021-2026)

  • 2.5 Gelatin Haemostatic Sponge Segment by Application

    • 2.5.1 Hospital

    • 2.5.2 Clinic

    • 2.5.3 Others

    • 2.5.4 Gelatin Haemostatic Sponge Sales by Application

      • 2.5.4.1 Global Gelatin Haemostatic Sponge Sale Market Share by Application (2021-2026)
      • 2.5.4.2 Global Gelatin Haemostatic Sponge Revenue and Market Share by Application (2021-2026)
      • 2.5.4.3 Global Gelatin Haemostatic Sponge Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Gelatin Haemostatic Sponge Breakdown Data by Company

    • 3.1.1 Global Gelatin Haemostatic Sponge Annual Sales by Company (2021-2026)

    • 3.1.2 Global Gelatin Haemostatic Sponge Sales Market Share by Company (2021-2026)

  • 3.2 Global Gelatin Haemostatic Sponge Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Gelatin Haemostatic Sponge Revenue by Company (2021-2026)

    • 3.2.2 Global Gelatin Haemostatic Sponge Revenue Market Share by Company (2021-2026)

  • 3.3 Global Gelatin Haemostatic Sponge Sale Price by Company

  • 3.4 Key Manufacturers Gelatin Haemostatic Sponge Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Gelatin Haemostatic Sponge Product Location Distribution

    • 3.4.2 Players Gelatin Haemostatic Sponge Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Gelatin Haemostatic Sponge by Geographic Region

  • 4.1 World Historic Gelatin Haemostatic Sponge Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Gelatin Haemostatic Sponge Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Gelatin Haemostatic Sponge Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Gelatin Haemostatic Sponge Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Gelatin Haemostatic Sponge Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Gelatin Haemostatic Sponge Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Gelatin Haemostatic Sponge Sales Growth

  • 4.4 APAC Gelatin Haemostatic Sponge Sales Growth

  • 4.5 Europe Gelatin Haemostatic Sponge Sales Growth

  • 4.6 Middle East & Africa Gelatin Haemostatic Sponge Sales Growth

• 5 Americas

  • 5.1 Americas Gelatin Haemostatic Sponge Sales by Country

    • 5.1.1 Americas Gelatin Haemostatic Sponge Sales by Country (2021-2026)

    • 5.1.2 Americas Gelatin Haemostatic Sponge Revenue by Country (2021-2026)

  • 5.2 Americas Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 5.3 Americas Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Gelatin Haemostatic Sponge Sales by Region

    • 6.1.1 APAC Gelatin Haemostatic Sponge Sales by Region (2021-2026)

    • 6.1.2 APAC Gelatin Haemostatic Sponge Revenue by Region (2021-2026)

  • 6.2 APAC Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 6.3 APAC Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Gelatin Haemostatic Sponge by Country

    • 7.1.1 Europe Gelatin Haemostatic Sponge Sales by Country (2021-2026)

    • 7.1.2 Europe Gelatin Haemostatic Sponge Revenue by Country (2021-2026)

  • 7.2 Europe Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 7.3 Europe Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Gelatin Haemostatic Sponge by Country

    • 8.1.1 Middle East & Africa Gelatin Haemostatic Sponge Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Gelatin Haemostatic Sponge Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Gelatin Haemostatic Sponge Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Gelatin Haemostatic Sponge Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Gelatin Haemostatic Sponge

  • 10.3 Manufacturing Process Analysis of Gelatin Haemostatic Sponge

  • 10.4 Industry Chain Structure of Gelatin Haemostatic Sponge

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Gelatin Haemostatic Sponge Distributors

  • 11.3 Gelatin Haemostatic Sponge Customer

• 12 World Forecast Review for Gelatin Haemostatic Sponge by Geographic Region

  • 12.1 Global Gelatin Haemostatic Sponge Market Size Forecast by Region

    • 12.1.1 Global Gelatin Haemostatic Sponge Forecast by Region (2027-2032)

    • 12.1.2 Global Gelatin Haemostatic Sponge Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Gelatin Haemostatic Sponge Forecast by Type (2027-2032)

  • 12.7 Global Gelatin Haemostatic Sponge Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Pfizer

    • 13.1.1 Pfizer Company Information

    • 13.1.2 Pfizer Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.1.3 Pfizer Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Pfizer Main Business Overview

    • 13.1.5 Pfizer Latest Developments

  • 13.2 Johnson & Johnson

    • 13.2.1 Johnson & Johnson Company Information

    • 13.2.2 Johnson & Johnson Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.2.3 Johnson & Johnson Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Johnson & Johnson Main Business Overview

    • 13.2.5 Johnson & Johnson Latest Developments

  • 13.3 B. Braun

    • 13.3.1 B. Braun Company Information

    • 13.3.2 B. Braun Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.3.3 B. Braun Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 B. Braun Main Business Overview

    • 13.3.5 B. Braun Latest Developments

  • 13.4 Gelita Medical

    • 13.4.1 Gelita Medical Company Information

    • 13.4.2 Gelita Medical Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.4.3 Gelita Medical Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Gelita Medical Main Business Overview

    • 13.4.5 Gelita Medical Latest Developments

  • 13.5 Cura Medical

    • 13.5.1 Cura Medical Company Information

    • 13.5.2 Cura Medical Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.5.3 Cura Medical Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Cura Medical Main Business Overview

    • 13.5.5 Cura Medical Latest Developments

  • 13.6 Aegis Lifesciences

    • 13.6.1 Aegis Lifesciences Company Information

    • 13.6.2 Aegis Lifesciences Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.6.3 Aegis Lifesciences Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Aegis Lifesciences Main Business Overview

    • 13.6.5 Aegis Lifesciences Latest Developments

  • 13.7 COLTENE

    • 13.7.1 COLTENE Company Information

    • 13.7.2 COLTENE Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.7.3 COLTENE Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 COLTENE Main Business Overview

    • 13.7.5 COLTENE Latest Developments

  • 13.8 Dispotech

    • 13.8.1 Dispotech Company Information

    • 13.8.2 Dispotech Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.8.3 Dispotech Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Dispotech Main Business Overview

    • 13.8.5 Dispotech Latest Developments

  • 13.9 Ferrosan Medical Devices

    • 13.9.1 Ferrosan Medical Devices Company Information

    • 13.9.2 Ferrosan Medical Devices Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.9.3 Ferrosan Medical Devices Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Ferrosan Medical Devices Main Business Overview

    • 13.9.5 Ferrosan Medical Devices Latest Developments

  • 13.10 EUCARE Pharmaceuticals

    • 13.10.1 EUCARE Pharmaceuticals Company Information

    • 13.10.2 EUCARE Pharmaceuticals Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.10.3 EUCARE Pharmaceuticals Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 EUCARE Pharmaceuticals Main Business Overview

    • 13.10.5 EUCARE Pharmaceuticals Latest Developments

  • 13.11 BOENMED

    • 13.11.1 BOENMED Company Information

    • 13.11.2 BOENMED Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.11.3 BOENMED Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 BOENMED Main Business Overview

    • 13.11.5 BOENMED Latest Developments

  • 13.12 Medelast

    • 13.12.1 Medelast Company Information

    • 13.12.2 Medelast Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.12.3 Medelast Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Medelast Main Business Overview

    • 13.12.5 Medelast Latest Developments

  • 13.13 JIAXING KENYUE

    • 13.13.1 JIAXING KENYUE Company Information

    • 13.13.2 JIAXING KENYUE Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.13.3 JIAXING KENYUE Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 JIAXING KENYUE Main Business Overview

    • 13.13.5 JIAXING KENYUE Latest Developments

  • 13.14 Medzeel Lifescience

    • 13.14.1 Medzeel Lifescience Company Information

    • 13.14.2 Medzeel Lifescience Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.14.3 Medzeel Lifescience Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 Medzeel Lifescience Main Business Overview

    • 13.14.5 Medzeel Lifescience Latest Developments

  • 13.15 Goodwill Lifesciences

    • 13.15.1 Goodwill Lifesciences Company Information

    • 13.15.2 Goodwill Lifesciences Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.15.3 Goodwill Lifesciences Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Goodwill Lifesciences Main Business Overview

    • 13.15.5 Goodwill Lifesciences Latest Developments

  • 13.16 Equimedical

    • 13.16.1 Equimedical Company Information

    • 13.16.2 Equimedical Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.16.3 Equimedical Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 Equimedical Main Business Overview

    • 13.16.5 Equimedical Latest Developments

  • 13.17 Healthium Medtech

    • 13.17.1 Healthium Medtech Company Information

    • 13.17.2 Healthium Medtech Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.17.3 Healthium Medtech Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Healthium Medtech Main Business Overview

    • 13.17.5 Healthium Medtech Latest Developments

  • 13.18 Septodont

    • 13.18.1 Septodont Company Information

    • 13.18.2 Septodont Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.18.3 Septodont Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.18.4 Septodont Main Business Overview

    • 13.18.5 Septodont Latest Developments

  • 13.19 Assut Europe

    • 13.19.1 Assut Europe Company Information

    • 13.19.2 Assut Europe Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.19.3 Assut Europe Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.19.4 Assut Europe Main Business Overview

    • 13.19.5 Assut Europe Latest Developments

  • 13.20 Nanchang Hushida Medical Technology

    • 13.20.1 Nanchang Hushida Medical Technology Company Information

    • 13.20.2 Nanchang Hushida Medical Technology Gelatin Haemostatic Sponge Product Portfolios and Specifications

    • 13.20.3 Nanchang Hushida Medical Technology Gelatin Haemostatic Sponge Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.20.4 Nanchang Hushida Medical Technology Main Business Overview

    • 13.20.5 Nanchang Hushida Medical Technology Latest Developments

• 14 Research Findings and Conclusion